Comparative Pharmacology
Head-to-head clinical analysis: LACTULOSE versus MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LACTULOSE versus MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE.
LACTULOSE vs MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lactulose is a non-absorbable disaccharide that is metabolized by colonic bacteria to short-chain fatty acids, primarily lactic acid and acetic acid, resulting in an osmotic effect that increases stool water content and softens stools. In hepatic encephalopathy, lactulose acidifies the colonic lumen, converting NH3 to NH4+, which is poorly absorbed, and reduces systemic ammonia levels.
Monobasic and dibasic sodium phosphate are phosphates that increase urinary phosphate concentration, leading to osmotic diuresis and acidification of urine. They also act as a source of phosphate for metabolic processes.
Constipation: 15-30 mL (10-20 g) orally once daily, increased to 45-60 mL (30-40 g) daily if needed. Hepatic encephalopathy: 30-45 mL (20-30 g) orally 3-4 times daily; titrate to produce 2-3 soft stools daily.
Oral: 1-2 tablets (each containing monobasic sodium phosphate 500 mg and dibasic sodium phosphate 750 mg) 4 times daily, taken with a full glass of water; rectal enema: 120 mL (monobasic sodium phosphate 19 g and dibasic sodium phosphate 7 g) as a single dose, administered rectally.
None Documented
Clinical Note
moderateL-Glutamine + Lactulose
"The therapeutic efficacy of Lactulose can be decreased when used in combination with L-Glutamine."
None Documented
1-2 hours (terminal elimination half-life for lactulose). However, its clinical effect is not dependent on systemic half-life; the drug acts locally in the colon.
Not applicable as a true terminal half-life; phosphate clearance is highly dependent on renal function and serum phosphate levels; in patients with normal renal function, serum phosphate returns to baseline within 4-6 hours after oral dose.
Primarily fecal (unaltered, >90%). Minimal renal excretion (<5% as metabolites). Very small amount (approximately 3%) excreted in urine as unchanged drug.
Primarily renal excretion as phosphate ions; >95% eliminated via urine; minimal biliary/fecal elimination.
Category C
Category C
Laxative
Laxative